Literature DB >> 18974467

Risk of venous thrombosis in patients with hepatic malignancies undergoing surgical resection.

Todd J Yates1, Marwan Abouljoud, Angela Lambing, Philip Kuriakose.   

Abstract

The risk of venous thrombosis is well documented in patients with malignancies, those undergoing abdominal surgery, and those undergoing hepatic resection for malignancy. This study was undertaken to determine whether there was a difference in the risk of thrombosis between those undergoing resection for hepatic metastases and primary hepatic malignancies. We performed a retrospective chart review of patients undergoing initial surgical resection for hepatic malignancies, primarily to determine whether there was a difference in the incidence of venous thrombosis between those with primary and secondary malignancies. Ninety-nine patients underwent surgical resection for either primary or secondary hepatic malignancies from 2001 to 2006. Seven of these patients, all with secondary hepatic malignancy, developed venous thrombosis within 3 months of resection. This retrospective review reveals that a clinical presentation of venous thrombosis is significantly more common among patients undergoing hepatic resection for secondary malignancy than those undergoing resection for primary cancer of the liver. Special attention with regard to prophylaxis for thrombosis may be required in these patients.

Entities:  

Mesh:

Year:  2008        PMID: 18974467

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


  2 in total

1.  Post-operative pharmacologic thromboprophylaxis after major hepatectomy: does peripheral venous thromboembolism prevention outweigh bleeding risks?

Authors:  Srinevas K Reddy; Ryan S Turley; Andrew S Barbas; Jennifer L Steel; Allan Tsung; J Wallis Marsh; Bryan M Clary; David A Geller
Journal:  J Gastrointest Surg       Date:  2011-06-21       Impact factor: 3.452

2.  Venous thromboembolism after hepatic resection: analysis of 5,706 patients.

Authors:  Ryan S Turley; Srinevas K Reddy; Cynthia K Shortell; Bryan M Clary; John E Scarborough
Journal:  J Gastrointest Surg       Date:  2012-06-30       Impact factor: 3.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.